跳至主導覽
跳至搜尋
跳過主要內容
國立成功大學 首頁
English
中文
在 國立成功大學 搜尋內容
首頁
概要
研究單位
研究成果
專案
學生論文
設備
獎項
活動
查看斯高帕斯 (Scopus) 概要
林 聖翔
教授
臨床醫學研究所
電子郵件
shlin922
mail.ncku.edu
tw
h-index
3468
引文
30
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2001
2026
每年研究成果
概覽
指紋
網路
專案
(10)
研究成果
(202)
類似的個人檔案
(6)
監製作品
(24)
指紋
查看啟用 Sheng-Hsiang Lin 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Acetylsalicylic Acid
21%
Acute Coronary Syndrome
31%
Acute Heart Infarction
30%
Adverse Event
13%
Adverse Outcome
33%
All Cause Mortality
13%
Antiplatelet
27%
Atrial Fibrillation
25%
Biological Marker
21%
Brain Hemorrhage
15%
Brain Ischemia
25%
Breast Cancer
21%
Cardiotoxicity
12%
Cardiovascular Disease
12%
Cerebrovascular Accident
32%
Chemotherapy
16%
Chronic Kidney Failure
31%
Clopidogrel
23%
Cohort Study
100%
Comorbidity
12%
Congestive Heart Failure
21%
Diseases
41%
Drug Resistance
20%
End Stage Renal Disease
17%
Epidermal Growth Factor Receptor
14%
Fibrosing Alveolitis
40%
Hemodialysis
15%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
36%
Immune Checkpoint Inhibitor
13%
Infection
40%
Liver Cell Carcinoma
30%
Malignant Neoplasm
43%
Metformin
20%
Monotherapy
37%
Neoplasm
15%
Nintedanib
20%
Non Insulin Dependent Diabetes Mellitus
20%
Non Small Cell Lung Cancer
30%
Nonhodgkin Lymphoma
31%
Observational Study
11%
Ovary Cancer
30%
Ovary Carcinoma
22%
Pitavastatin
16%
Protein Tyrosine Kinase Inhibitor
23%
Sleep Disordered Breathing
20%
Standardized Incidence Ratio
17%
Statin (Protein)
57%
Syndrome
20%
Ticagrelor
20%
Warfarin
15%
Medicine and Dentistry
Adverse Outcome
13%
Antiplatelet
12%
Antithrombotic
11%
Apoplexy
41%
Biological Marker
21%
Brain Ischemia
24%
Breast Cancer
10%
Cancer
15%
Cancer Risk
13%
Chronic Kidney Disease
11%
Cohort Analysis
40%
Congestive Heart Failure
14%
Crohn's Disease
17%
Cytokine
12%
Diseases
21%
DNA Polymorphism
11%
End Stage Renal Disease
14%
Glycon
20%
Hazard Ratio
54%
Hematologic Malignancy
11%
Hemodialysis
15%
Hepatocellular Carcinoma
30%
Immune Checkpoint Inhibitor
14%
Inflammatory Bowel Disease
20%
Kidney Function
10%
Krukenberg Tumor
12%
Lifespan
20%
Logistic Regression Analysis
14%
Malignant Neoplasm
22%
Maturity Onset Diabetes of the Young
20%
Monotherapy
11%
Neoplasm
12%
Non-Hodgkin Lymphoma
31%
Odds Ratio
11%
Ovarian Cancer
20%
Patient with Epilepsy
11%
Patient with Type 2 Diabetes
12%
Peritoneal Dialysis
32%
Pre-Eclampsia
20%
Proportional Hazards Model
11%
Recurrent Pregnancy Loss
20%
Retrospective Cohort Study
15%
Retrospective Study
12%
Standardized Incidence Ratio
29%
Systemic Lupus Erythematosus
20%
Thymic Carcinoma
14%
Thymus Cancer
14%
Ulcerative Colitis
17%
Upregulation
11%
Warfarin
15%
Keyphrases
Acute Coronary Syndrome
11%
Acute Kidney Injury
10%
Adjusted Hazard Ratio
23%
Adolescent Perspectives
10%
Adverse Events
11%
All-cause Mortality
17%
Antiplatelet Therapy
10%
Asia
22%
Aspirin
10%
Atrial Fibrillation
16%
Bidirectional Association
30%
Cancer Risk
12%
Capture-recapture
15%
Capture-recapture Models
20%
Cardiotoxicity
10%
Cardiovascular Outcomes
13%
Cause of Death
12%
Clinical Outcomes
21%
Confidence Interval
17%
Familial Aggregation
11%
Footnotes
14%
Health Information Sources
10%
Hemorrhagic Stroke
13%
Infrared Photos
10%
Low Risk
11%
Maintenance Hemodialysis Patients
11%
Major Adverse Cardiovascular Events
23%
National Cohort Study
62%
National Health Insurance Research Database (NHIRD)
12%
Niacin
20%
Non-Hodgkin Lymphoma
30%
Non-psychotic Disorders
20%
Outer Mitochondrial Membrane
10%
Patients with Breast Cancer
20%
Percutaneous Coronary Intervention
16%
Peritoneal Dialysis
21%
Peritoneal Dialysis Patients
15%
Photoenergy
10%
Pitavastatin
16%
Population-based Study
40%
Primary Sjgren's Syndrome
20%
Safety Outcomes
12%
Schizophrenia
14%
Schizophrenic Patients
15%
Standardized Incidence Ratio
10%
Statin Use
20%
Statins
29%
Taiwan
47%
Taiwanese
23%
Vulnerability Indicators
12%
